Amja Manullang1, Yueh-Lun Lee2, Vincent Laiman1,3, Jer-Hwa Chang This email address is being protected from spambots. You need JavaScript enabled to view it.4,5, Hsiao-Chi Chuang  This email address is being protected from spambots. You need JavaScript enabled to view it.4,6,7

1 International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
2 Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
3 Department of Anatomical Pathology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
4 School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan
5 Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
6 Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan
7 Cell Physiology and Molecular Image Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan

Received: January 17, 2022
Revised: April 6, 2022
Accepted: April 27, 2022

 Copyright The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are cited.

Download Citation: ||  

  • Download: PDF

Cite this article:

Manullang, A., Lee, Y.L., Laiman, V., Chang, J.H., Chuang, H.C. (2022). Associations between Ozone and Emphysema: A Systematic Review and Meta-analysis. Aerosol Air Qual. Res. 22, 220027.


  • Associations between air pollution and emphysema were examined using meta-analysis.
  • O3 is associated with emphysema progression.
  • Emphysema is a phenotype of COPD for air pollution exposure.


Air pollution is widely viewed as a serious threat to human health and a contributor to deaths. Air pollution appears to be linked to the progression of emphysema, according to epidemiological data. The objective of this study was to examine associations between air pollution and the progression of emphysema using a meta-analysis. A meta-analysis was conducted according to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) protocol. A systematic literature search was conducted using the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Medline, Embase, PubMed, and Web of Science bibliographic databases. A random-effects model for the meta-analysis was implemented to summarize effect estimates of sufficiently comparable outcomes and pollutants (e.g.: particulate matter, nitrogen oxides and ozone), and the results were visualized in forest plots. We observed that a 1-ppb rise in O3 was associated with a 0.30 increase in the percent emphysema progression (95% CI: 0.02, 0.57, p < 0.05). In contrast, no significant association was found between PM2.5 or NO2 exposure and the percent change in emphysema. Increasing O3 concentrations may have an impact on and exacerbate human health conditions such as emphysema and respiratory diseases. Air quality and climate change should be concerns for future environmental policies and protection measures.

Keywords: Air pollution, COPD, Emphysema, Meta-analysis, Ozone


For decades, outdoor air pollution has been the focus of concern around the world, due in part to the development of the global economy and urbanization. Air pollution has long been recognized as having serious effects on human health and being a contributing factor in deaths and illnesses (Burnett et al., 2018; WHO, 2018). The major pollutants that have been linked to adverse health impacts are particulate matter (PM), which include PM of < 10 µm in aerodynamic diameter (PM10), < 2.5 µm (PM2.5), and < 0.1 µm (ultrafine particles; UFP) (WHO, 2013; Guarnieri and Balmes, 2014). According to studies conducted in Hong Kong, Taiwan, and China, for every 10-µg m–3 increase in PM10 levels, increases of the risk of heart disease (CVD) death by 0.36% and of respiratory diseases death rates by 0.42% were detected, and for each 10-µg m3 rise in PM2.5 concentrations, mortality from cardiovascular diseases (CVDs) and respiratory illnesses respectively increased by 0.63% and 0.75% (Lu et al., 2015). Mortality evaluation research of PM2.5 in a population of more than 40 million Europeans estimated that reducing PM2.5 concentrations to 10 µg m3 would reduce total deaths by 0.3% to 9.0% (Ballester et al., 2008; Faustini et al., 2014). Nitrogen dioxide (NO2) is a highly toxic gas that can be created both outdoors and indoors from various emissions sources (i.e., road traffic and cooking). Oxidation of nitrogen oxide (NO) by ozone (O3) is the principal source of NO2. Tropospheric O3 is produced by a complex chain of events including sunlight (ultraviolet radiation), NO2, and hydrocarbons. According to previous reports, each 10-µg m3 rise in NO2 and O3 results in excess relative risks of 1.2% and 2.0%, respectively (Fattore et al., 2011; Khaniabadi et al., 2017).

Chronic obstructive pulmonary disease (COPD) is a chronic respiratory illness which manifests as air space dilatation and parenchymal destruction (GOLD, 2017). Tobacco smoking is one of the factors associated with COPD (CDC, 2012). Furthermore, a growing body of research has found that non-smokers can suffer from COPD as a result of exposure to indoor and outdoor air pollution (Salvi and Barnes, 2009). Epidemiological evidence has established strong links among various air pollutants and greater risks of respiratory diseases, particularly in people who have an underlying chronic lung disease such as COPD (Kim et al., 2018). COPD prevalence is associated with greater amounts of PM2.5 (OR) = 1.52) and PM10 (OR = 1.08) per 5 µg m3, along with NO2 (OR = 1.12) per 10 µg m3 (Doiron et al., 2019). Numerous studies reported links between air pollution and elevated chances of COPD and declines in lung function (Duan et al., 2020; Elbarbary et al., 2020). Hospitalizations and cardiovascular and respiratory mortality have all been linked to air pollution (Berend, 2016). Small airways also contribute as a major site of resistance in obstructive lung diseases (McDonough et al., 2011; Hogg et al., 2013). COPD is a chronic obstruction of airflow due to a combination of small airway illness (obstructive bronchiolitis) and parenchymal damage (emphysema) (Stewart and Criner, 2013). Although air pollution is recognized as a risk factor for COPD, the phenotypes of air pollution-associated COPD remain unclear.

Emphysema is a lung disease defined by the growth of persistent air gaps distal to the terminal bronchioles (Shah et al., 2017). The disease process can cause hyperinflation, as implied by its Greek name, emphusma, which means inflation (Kemp et al., 2009). The progression of emphysema is linked to a reduction in the lower respiratory tract neutrophil elastase inhibitory capacity that is induced by cigarette smoking (Ogushi et al., 1991). However, lung function decline was shown to be associated with changes in air pollution in a study of 1391 non-smokers and 20-year estimated concentrations of sulfur dioxide (SO2), O3, and indoor PM10 exposure (Abbey et al., 1998). Decreased levels of ambient air pollutants per 1.0 ppb of O3, SO2, NO2, and carbon monoxide (CO), and per 1.0 µg m3 of PM2.5 and PM10 were associated with lower emphysema death rates (Kravchenko et al., 2014). Furthermore, among individuals who resided within 1 km of a cement factory, the level of air pollution exposure appeared to affect the prevalence of emphysema, with the OR of those who were more frequently exposed to air pollution being equal to that of smokers (Lee et al., 2016). A recent cohort study from the Multi-Ethnic Study of Atherosclerosis (MESA) Air and Lung Study, which was performed in six large cities across the United States, concluded that long-term exposure to ambient air pollutants such as nitrogen oxides (NOx) and O3 was found to be substantially linked with progression in emphysema with a greater decrease in both forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) as assessed by chest computed tomographic (CT) imaging and lung function (Wang et al., 2019). A 4.4-µg m3 increase in PM10 exposure on a yearly basis was associated with a 0.13 liter decrease in the FVC (Kwon et al., 2020). Prolonged O3 exposure to a 5-ppb increase was associated with an increase of 0.94 and 1.60 in the percentages of emphysema and air trapping, respectively (Paulin et al., 2020). In a study of COPD patients, a unit increases in PM2.5 and O3 were both linked to the presence of emphysema in each lung lobe, particularly in the upper long lobes, which were associated with 2.772- and 3.052-fold increases (Tung et al., 2021). The evidence for a causal relationship between air pollution and emphysema in humans remains sparse. A meta-analysis conducted by ESCAPE (European Study of Cohorts for Air Pollution Effects) found no consistent associations between current long-term average air pollution levels and symptoms of chronic bronchitis in adult European populations (Cai et al., 2014). However, a few epidemiological evidence indicates an association between air pollution and the development of emphysema in COPD patients. Therefore, the objective of this study was to examine associations between air pollution and the progression of emphysema using a meta-analysis.


2.1 Data Sources and Search Strategies

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria were followed in reporting this study (Moher et al., 2009). This study's protocol was verified with PROSPERO ( with the number CRD42021290374. The PubMed, Embase, Medline, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science bibliographic databases were searched without restriction on publication year but restricted solely to English full-text items to find journal papers published that reported study results related to our study objective. Additional eligible studies were searched by manually screening relevant meta-analyses, reviews, and reference lists, including in Google Scholar. Terms related to the study were obtained using the PEOS tool for systematic review; Population ("general population," "patients"), Exposure ("air pollution," "ozone," "particulate matter," "nitrogen oxides"), Outcome ("pulmonary emphysema," "emphysema," and "lung emphysema"): Study design ("Human study," "cohort and cross-sectional study"). Endnote reference manager software, full version X9, was used to compile the results of the database searches.

2.2 Study Selection and Eligibility Criteria

All eligible studies were collected as full texts after removing duplicates, and reference sections were searched for additional qualifying articles. This was checked by two investigators (A.M and V.L) through screening the titles and abstracts. Any inconsistencies discovered during the screening process were resolved through discussion. If a study met the following requirements, it was included in the current review: (1) a cohort and cross-sectional study assessing a prognosis developing emphysema as a result of an exposure; (2) a research article with a clear method and study design; and (3) an original article with primary sources and provided in full-text English. However, studies that were (1) clearly stated as animal studies, (2) population expose in occupational settings (3) preliminary study or without clear method and complete data including abstracts, conferences, book chapters, reviews, protocols, posters, or studies that did not investigate exposure increments for emphysema development were excluded.

2.3 Data Extraction and Quality Assessment

We extracted data from the primary articles of potential studies and approached the corresponding authors for any relevant data we discovered to be missing from the included articles. Reference information (authors and publication year), cohort details (cohort name, country, and study population), subject characteristics (mean age and sex), image analysis (chest CT), and details on air pollutants, such as PM2.5 (µg m3), PM10 (µg m3), NOx (ppb), NO2 (ppb), and O3 (ppb), were all collected. For each of the study units, such as effect estimation, the beta (β) coefficient was used to determine the association between air pollution and emphysema progression. Since some of the effect estimates were provided in different units of an interquartile range (IQR) increase, we normalized those first to beta (β) coefficients. Data from the articles were entered into an Excel (Microsoft, Redmond, WA, USA) document.

2.4 Data Synthesis and Analyses

Review Manager software (RevMan vers. 5.4.1) was utilized for the meta-analysis. Since most of the included studies provided effect estimates as IQRs, we standardized effect estimates per a 1-µg m3 increase in each pollutant. Heterogeneity among studies was assessed using the I2 value. Low, moderate, and high heterogeneity levels were respectively indicated by scores of 25%, 50%, and 75% (Higgins et al., 2003). Low heterogeneity (I2 of ≤ 25%) implies a homogeneous data series and, in general, the analytical feasibility using a fixed-effect model. On the contrary, high heterogeneity (I2 of ≥ 75%) reflects significantly true variability of the data, justifying the need for a random-effects model (Haidich, 2010).


In the beginning, 2970 publications were collected. After compiling search results and eliminating duplicates, 1937 studies remained for title/abstract screening. Additional Google Scholar searches were performed to identify potential published articles of gray source materials or the latest publications during the review process. However, no new research or reviews were discovered. The PRISMA flow diagrams showed the outcomes of the search strategy and screening process (Fig. 1). In total, 1930 studies were discarded because they did not fulfill the inclusion criteria. They were excluded for various reasons, including animal studies (n = 328), conference abstracts (n = 43), and review studies (n = 59), as well as in a non-English language (n = 92), unrelated topics (n = 1295), and occupational exposure (n = 113). Due to a limit of information on the link between air pollution and the development of emphysema, two additional studies were eliminated. Finally, five studies were eligible for inclusion in the final analysis for this study (Adar et al., 2015; Wang et al., 2019; Kwon et al., 2020; Paulin et al., 2020; Tung et al., 2021). The five studies were conducted in three countries: The United States (n = 3), South Korea (n = 1), and Taiwan (n = 1). The combined studies yielded a total of 23,120 persons whose average ages were 60–72 years. The sample sizes for these studies ranged 86–6860 persons. The evolution of emphysema was monitored using computed tomography (CT) and high-resolution (HR)-CT (Table 1).

Fig. 1. Flowchart of the assessment of potential studies.Fig. 1. Flowchart of the assessment of potential studies.

Table 1. Summary of characteristics of studies included in the systematic review.

Population exposed in occupational settings was excluded from this study because the effect may differ from that experienced by the general population due to the exclusivity and consistency of exposure resulting from the job type and working hours, which also makes it possible to summarize the possible causal relationship. Furthermore, animal studies that were considerably influenced by the same conditions were removed.

PM2.5 results from the three studies were considered for quantitative synthesis. The overall effect of PM2.5 concentrations was 0.21 (95% (CI): –0.04, 0.46; p > 0.05) (Fig. 2). In terms of NO2 concentration, two studies were used for quantitative synthesis. The overall effect of NO2 exposures was 1.12 (95% CI: –1.14, 3.38; p > 0.05) (Fig. 3). A quantitative synthesis was also conducted using three studies that investigated the O3 effect on emphysema. The overall effect of O3 exposure estimates was 0.30 (95% CI: 0.02, 0.57; p < 0.05) (Fig. 4). Results indicated that a 1-ppb rise in O3 corresponded to a 0.30 percentage point increase in percent emphysema progression.

Fig. 2. Forest plot of associations between PM2.5 concentrations and percent emphysema.Fig. 2. Forest plot of associations between PM2.5 concentrations and percent emphysema.

Fig. 3. Forest plot of associations between NO2 concentration and percent emphysema.Fig. 3. Forest plot of associations between NO2 concentration and percent emphysema.

Fig. 4. Forest plot of associations between O3 concentration and percent emphysema.Fig. 4. Forest plot of associations between O3 concentration and percent emphysema.

Our findings are consistent with the most recently published articles we investigated (Adar et al., 2015; Wang et al., 2019; Kwon et al., 2020; Paulin et al., 2020; Tung et al., 2021). We observed that effect estimates of neither PM2.5 nor NO2 showed an association with emphysema. However, in previous work, PM2.5 exposure was associated with decreased lung function, emphysematous lesions, and increased inflammation (Zhao et al., 2019; Kim et al., 2021). Reduced NO2 levels were also associated with a lower risk of death from emphysema (Kravchenko et al., 2014; Huangfu and Atkinson, 2020). Other studies, however, discovered no association between PM2.5 and emphysema progression after 10 years of follow-up, and neither long-term NO2 exposure nor emphysema phenotypes were shown to be associated (Wang et al., 2019; Kwon et al., 2020).

The amount of O3 in the air has significant impacts on the development of respiratory illnesses (Amann, 2008). According to a study from Rome, Italy, a photochemical pollutant (O3) was a predictor of acute respiratory disorders (Fusco et al., 2001). In our study, exposure to O3 was found to be significantly associated with emphysema progression in COPD patients. The association between yearly O3 and respiratory deaths was 0.99 per 10 ppb (Huangfu and Atkinson, 2020). An increasing concentration of O3 and a continuous change in temperature were also associated with acute exacerbation of COPD in older people (Lin et al., 2018). Therefore, exposure to O3 is a risk factor for emphysema in COPD patients.

Our study had a substantial level of heterogeneity (I2 ≥ 75%) in all of the analyses of PM2.5, NO2, and O3 concentrations. Since I2 is affected by the sample size of the included studies, a high I2 does not always imply that the study effects were dispersed over a wide range (Rücker et al., 2008). A random effects model was additionally performed in the analysis. This model implies a true distribution of population associations, namely the significance of the relationship between pollutants and the development of emphysema in a study population that differs from other research populations. The variation in observed associations might be attributable to differences in study characteristics (e.g., different study countries and control for confounders). However, we were unable to perform any sub-group analyses to determine the source of heterogeneity because of the limited number of included studies, and the results are unlikely to change our overall estimates. As the occupational setting was not considered, it could also be a limitation in this study.


Significant relationships between O3 and emphysema were reported in our systematic review and meta-analysis. Increasing ozone concentrations may have an impact on and exacerbate human health conditions such as emphysema and respiratory diseases. Air quality and climate change should be concerns for future environmental policies and protection measures.


The authors heartedly thank to Nguyen Thanh Tung for technical assistance during this project.


Conflict of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

All authors contributed substantially to the concept and design of the study, drafting of the article, and critically revising the manuscript for important intellectual content. All authors have read and approved the final version of the manuscript for publication.


This study was funded by the Ministry of Science and Technology of Taiwan (MOST 109-2314-B-038-093-MY3).


  1. Abbey, D.E., Burchette, R.J., Knutsen, S.F., McDonnell, W.F., Lebowitz, M.D., Enright, P.L. (1998). Long-term particulate and other air pollutants and lung function in nonsmokers. Am. J. Respir. Crit. Care Med. 158, 289–298.

  2. Adar, S.D., Kaufman, J.D., Diez-Roux, A.V., Hoffman, E.A., D'Souza, J., Stukovsky, K.H., Rich, S.S., Rotter, J.I., Guo, X., Raffel, L.J., Sampson, P.D., Oron, A.P., Raghunathan, T., Barr, R.G. (2015). Air pollution and percent emphysema identified by computed tomography in the Multi-Ethnic study of Atherosclerosis. Environ. Health Perspect. 123, 144–151.​ehp.1307951

  3. Amann, M. (2008). Health Risks of Ozone from Long-range Transboundary Air Pollution. WHO Regional Office Europe, Denmark. 

  4. Ballester, F., Medina, S., Boldo, E., Goodman, P., Neuberger, M., Iñiguez, C., Künzli. (2008). Reducing ambient levels of fine particulates could substantially improve health: A mortality impact assessment for 26 European cities. J. Epidemiol. Community Health 62, 98–105.

  5. Berend, N. (2016). Contribution of air pollution to COPD and small airway dysfunction. Respirology 21, 237–244.

  6. Burnett, R., Chen, H., Szyszkowicz, M., Fann, N., Hubbell, B., Pope, C.A., 3rd, Apte, J.S., Brauer, M., Cohen, A., Weichenthal, S., Coggins, J., Di, Q., Brunekreef, B., Frostad, J., Lim, S.S., Kan, H., Walker, K.D., Thurston, G.D., Hayes, R.B., Lim, C.C., et al. (2018). Global estimates of mortality associated with long-term exposure to outdoor fine particulate matter. PNAS. 115, 9592–9597.

  7. Cai, Y., Schikowski, T., Adam, M., Buschka, A., Carsin, A.E., Jacquemin, B., Marcon, A., Sanchez, M., Vierkötter, A., Al-Kanaani, Z., Beelen, R., Birk, M., Brunekreef, B., Cirach, M., Clavel-Chapelon, F., Declercq, C., de Hoogh, K., de Nazelle, A., Ducret-Stich, R.E., Valeria Ferretti, V., et al. (2014). Cross-sectional associations between air pollution and chronic bronchitis: an ESCAPE meta-analysis across five cohorts. Thorax 69, 1005–1014.​thoraxjnl-2013-204352

  8. Centers for Disease Control and Prevention (CDC) (2012). Chronic Obstructive Pulmonary Disease among Adults--United States, 2011. MMWR. Morbidity and mortality weekly report 61, 938–943. 

  9. Doiron, D., de Hoogh, K., Probst-Hensch, N., Fortier, I., Cai, Y., De Matteis, S., Hansell, A.L. (2019). Air pollution, lung function and COPD: Results from the population-based UK Biobank study. Eur. Respir. J. 54, 1802140.

  10. Duan, R.R., Hao, K., Yang, T. (2020). Air pollution and chronic obstructive pulmonary disease. Chronic Dis. Transl. Med. 6, 260–269.

  11. Elbarbary, M., Oganesyan, A., Honda, T., Kelly, P., Zhang, Y., Guo, Y., Morgan, G., Guo, Y., Negin, J. (2020). Ambient air pollution, lung function and COPD: Cross-sectional analysis from the WHO Study of AGEing and adult health wave 1. BMJ Open Respir. Res. 7, e000684.

  12. Fattore, E., Paiano, V., Borgini, A., Tittarelli, A., Bertoldi, M., Crosignani, P., Fanelli, R. (2011). Human health risk in relation to air quality in two municipalities in an industrialized area of northern Italy. Environ. Res. 111, 1321–1327.

  13. Faustini, A., Rapp, R., Forastiere, F. (2014). Nitrogen dioxide and mortality: Review and meta-analysis of long-term studies. Eur. Respir. J. 44, 744–753.​00114713

  14. Fusco, D., Forastiere, F., Michelozzi, P., Spadea, T., Ostro, B., Arcà, M., Perucci, C.A. (2001). Air pollution and hospital admissions for respiratory conditions in Rome, Italy. Eur. Respir. J. 17, 1143–1150.

  15. Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2017). GOLD 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD. 

  16. Guarnieri, M., Balmes, J.R. (2014). Outdoor air pollution and asthma. Lancet 383, 1581–1592.

  17. Haidich, A.B. (2010). Meta-analysis in medical research. Hippokratia 14, 29–37.

  18. Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G. (2003). Measuring inconsistency in meta-analyses. BMJ 327, 557–560.

  19. Hogg, J.C., McDonough, J.E., Suzuki, M. (2013). Small airway obstruction in COPD: New insights based on micro-CT imaging and MRI imaging. CHEST 143, 1436–1443.​10.1378/chest.12-1766

  20. Huangfu, P., Atkinson, R. (2020). Long-term exposure to NO2 and O3 and all-cause and respiratory mortality: A systematic review and meta-analysis. Environ. Int. 144, 105998.​10.1016/j.envint.2020.105998

  21. Kemp, S.V., Polkey, M.I., Shah, P.L. (2009). The epidemiology, etiology, clinical features, and natural history of emphysema. Thoracic Surgery Clin. 19, 149–158.​thorsurg.2009.03.003

  22. Khaniabadi, Y.O., Goudarzi, G., Daryanoosh, S.M., Borgini, A., Tittarelli, A., De Marco, A. (2017). Exposure to PM10, NO2, and O3 and impacts on human health. Environ. Sci. Pollut. Res. 24, 2781–2789.

  23. Kim, D., Chen, Z., Zhou, L.F., Huang, S.X. (2018). Air pollutants and early origins of respiratory diseases. Chronic Dis. Transl. Med. 4, 75–94.

  24. Kim, Y., Bak, S.H., Kwon, S.O., Kim, H., Kim, W.J., Lee, C.Y. (2021). Association between long-term exposure to PM2.5 and lung imaging phenotype in CODA cohort. Atmosphere 12, 282.

  25. Kravchenko, J., Akushevich, I., Abernethy, A.P., Holman, S., Ross Jr, W.G., Lyerly, H.K. (2014). Long-term dynamics of death rates of emphysema, asthma, and pneumonia and improving air quality. Int. J. Chron. Obstruct. Pulmon. Dis. 9, 613–627.​S59995

  26. Kwon, S.O., Hong, S.H., Han, Y.J., Bak, S.H., Kim, J., Lee, M.K., London, S.J., Kim, W.J., Kim, S.Y. (2020). Long-term exposure to PM10 and NO2 in relation to lung function and imaging phenotypes in a COPD cohort. Respir. Res. 21, 247.

  27. Lee, H.S., Lee, C.G., Kim, D.H., Song, H.S., Jung, M.S., Kim, J.Y., Park, C.H., Ahn, S.C., Yu, S.D. (2016). Emphysema prevalence related air pollution caused by a cement plant. Ann. Occup. Environ. Med. 28, 17.

  28. Lin, M.T., Kor, C.T., Chang, C.C., Chai, W.H., Soon, M.S., Ciou, Y.S., Bin Lian, I., Chang, C.C. (2018). Association of meteorological factors and air NO2 and O3 concentrations with acute exacerbation of elderly chronic obstructive pulmonary disease. Sci. Rep. 8, 10192.​s41598-018-28532-5

  29. Lu, F., Xu, D., Cheng, Y., Dong, S., Guo, C., Jiang, X., Zheng, X. (2015). Systematic review and meta-analysis of the adverse health effects of ambient PM2.5 and PM10 pollution in the Chinese population. Environ. Res. 136, 196–204.

  30. McDonough, J.E., Yuan, R., Suzuki, M., Seyednejad, N., Elliott, W.M., Sanchez, P.G., Wright, A.C., Gefter, W.B., Litzky, L., Coxson, H.O., Paré, P.D., Sin, D.D., Pierce, R.A., Woods, J.C., McWilliams, A.M., Mayo, J.R., Lam, S.C., Cooper, J.D., Hogg, J.C. (2011). Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N. Engl. J. Med. 365, 1567–1575.

  31. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 339, b2535.​10.1136/bmj.b2535

  32. Ogushi, F., Hubbard, R.C., Vogelmeier, C., Fells, G.A., Crystal, R.G. (1991). Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase. J. Clin. Invest. 87, 1060–1065.

  33. Paulin, L.M., Gassett, A.J., Alexis, N.E., Kirwa, K., Kanner, R.E., Peters, S., Krishnan, J.A., Paine, R., Dransfield, M., Woodruff, P.G., Cooper, C.B., Barr, R.G., Comellas, A.P., Pirozzi, C.S., Han, M., Hoffman, E.A., Martinez, F.J., Woo, H., Peng, R.D., Fawzy, A., et al. (2020). Association of long-term ambient ozone exposure with respiratory morbidity in smokers. JAMA Intern. Med. 180, 106–115.

  34. Rücker, G., Schwarzer, G., Carpenter, J.R, Schumacher, M. (2008). Undue reliance on I2 in assessing heterogeneity may mislead. BMC Med. Res. Method. 8, 79.​1471-2288-8-79

  35. Salvi, S.S., Barnes, P.J. (2009). Chronic obstructive pulmonary disease in non-smokers. Lancet 374, 733–743.

  36. Shah, P.L., Herth, F.J., Geffen, W.H., van, Deslee, G., Slebos, D.J. (2017). Lung volume reduction for emphysema. Lancet Respir. Med. 5, 147–156.

  37. Stewart, J.I., Criner, G.J. (2013). The small airways in chronic obstructive pulmonary disease: Pathology and effects on disease progression and survival. Curr. Opin. Pulm. Med. 19, 109–115.

  38. Tung, N.T., Ho, S.C., Lu, Y.H., Chen, T.T., Lee, K.Y., Chen, K.Y., Wu, C.D., Chung, K.F., Kuo, H.P., Thao, H.N.X., Dung, H.B., Thuy, T.P.C., Wu, S.M., Kou, H.Y., Lee, Y.L., Chuang, H.C. (2021). Association between air pollution and lung lobar emphysema in COPD. Front. Med. 8, 705792.

  39. Wang, M., Aaron, C.P., Madrigano, J., Hoffman, E.A., Angelini, E., Yang, J., Laine, A., Vetterli, T.M., Kinney, P.L., Sampson, P.D., Sheppard, L.E., Szpiro, A.A., Adar, S.D., Kirwa, K., Smith, B., Lederer, D.J., Diez-Roux, A.V., Vedal, S., Kaufman, J.D., Barr, R.G. (2019). Association between long-term exposure to ambient air pollution and change in quantitatively assessed emphysema and lung function. JAMA 322, 54–-556.

  40. World Health Organization (WHO) (2013). Health Effects of Particulate Matter. Policy Implications for Countries in Eastern Europe, Caucasus and Central Asia. WHO Regional Office for Europe, Denmark. 

  41. World Health Organization (WHO) (2018). Burden of Disease from Ambient Air Pollution for 2016. World Health Organization, Switzerland. 

  42. Zhao, J., Li, M., Wang, Z., Chen, J., Zhao, J., Xu, Y., Wei, X., Wang, J., Xie, J. (2019). Role of PM2.5 in the development and progression of COPD and its mechanisms. Respir. Res. 20, 120.

Share this article with your colleagues 


Subscribe to our Newsletter 

Aerosol and Air Quality Research has published over 2,000 peer-reviewed articles. Enter your email address to receive latest updates and research articles to your inbox every second week.

77st percentile
Powered by
   SCImago Journal & Country Rank

2021 Impact Factor: 4.53
5-Year Impact Factor: 3.668

Aerosol and Air Quality Research partners with Publons

Aerosol and Air Quality Research partners with Publons

CLOCKSS system has permission to ingest, preserve, and serve this Archival Unit
CLOCKSS system has permission to ingest, preserve, and serve this Archival Unit

Aerosol and Air Quality Research (AAQR) is an independently-run non-profit journal that promotes submissions of high-quality research and strives to be one of the leading aerosol and air quality open-access journals in the world. We use cookies on this website to personalize content to improve your user experience and analyze our traffic. By using this site you agree to its use of cookies.